Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 473-478

  Bokarewa, Maria I ^a,b   Bremme, Katarina ^a   Blombäck, Margareta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activated protein C; Factor V; Pregnancy; Risk factors; Thrombosis

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MUTATION; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; ADOLESCENT; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY;

BLOOD CLOTTING FACTOR 5; PRIMER DNA;

ADOLESCENT; ADULT; BASE SEQUENCE; DNA PRIMERS; FACTOR V; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 0029664684     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1496.x     Document Type: Article

References (31)

1. Bertina, R.M., Koeleman, B.P.C., Koster, F., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
2. Blombäck, M. (1991) Changes in blood coagulation and fibrinolysis during pregnancy and the menstrual cycle: new methods for detecting the changes. Advances in Contraception, 7, (Suppl. 3), 259-272.
3. Blombäck, M., Eneroth, P., Landgren, B.M., Lagerström, M. & Anderson O. (1992) On the intraindividual and gender variability of haemostatic components. Thrombosis and Haemostasis, 67, 70-75.
4. Bokarewa, M.I., Bremme, K., Falk, G., Sten-Linder, M., Egberg, N. & Blombäck, M. (1995) Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene. Thrombosis Research, 78, 193-200.
5. Conard, J., Hollolou, M.H., van Dreden, P., Lecompte, T. & Samama, M. (1990) Thrombosis and pregnancy in congenital deficiencies of antithrombin III, protein C or protein S: study of 78 women. Thrombosis and Haemostasis, 63, 319-320.
6. Cook, G., Walker, I.D., McCall, F., Conkie, J.A. & Greer, I.A. (1994) Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy? British Journal of Haematology, 87, 873-875.
7. Dahlbäck, B., Carlsson, M. & Svensson, P.J. (1995) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
8. Dahlbäck, B. & Hildebrand, B. (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proceedings of the National Academy of Sciences of the United States of America, 91, 1396-1400.
9. Department of Health, Welsh Office, Scottish Home and Health Department of Health and Social Sevices, Northern Ireland (1991) Confidential enquiries into maternal death in the United Kingdom 1985-87. HMSO, London.
10. Doig, R.G., O'Malley, C.J., Dauer, R. & McGrath, K.M. (1994) An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable state. American Journal of Clinical Pathology, 102, 797-802.
11. Greengard, J.S., Eichinger, S., Griffin, J.H. & Bauer, K.A. (1994) Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-Gln mutation in the gene for factor V. New England Journal ojr Medicine. 331, 1559-1562.
12. Greer, I.A. (1994) Haemostasis and thrombosis in pregnancy. Haemostasis and Thrombosis, 3rd edn (ed. by A. L. Bloom, Ch. D. Forbes, D. P. Thomas and E. G. D. Tuddenham), pp. 1327-1333. Churchill Livingstone, Edinburgh.
13. Griffin, J., Evatt, B., Wideman, C. & Fernandez, J.A. (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood, 82, 1989-1993.
14. Halbmayer, W.M., Haushofer, A., Schön, R. & Fischer, M. (1994) The prevalence of poor anticoagulant response to activated protein C (APC-resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagulation and Fibrinolysis, 5, 51-57.
15. Hellgren, M., Svensson, P. & Dahlbäck, B. (1995) Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. American Journal of Obstetrics and Gynecology, 173, 210-213.
16. Henkens, C.M.A., Bom, V.J.J., Seinen, A.J. & van der Meer, J. (1995) Sensitivity to activated protein C. Influence of oral contraceptives and sex. Thrombosis and Haemostasis, 73, 402-404.
17. Hennekens, C.H. & Buring, J.E. (1987) Epidemiology in Medicine, Little Brown, Boston.
18. Kalafatis, M., Bertina, R.M., Rand, M.D. & Mann, K. (1995) Characterization of the molecular defect in factor V R506Q. Journal of Biological Chemistry, 270, 4053-4057.
19. Koeleman, B.P.C., Reitsma, P.H., Allart, C.F. & Bertina, R.M. (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood, 84, 1031-1035.
20. Koster, T., Rosendaal, F.R., de Ronde, H., Briët, K., Vanderbroucke, J.P. & Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet, 342, 1503-1507.
21. Miletich, J.P., Prescott, S.M., White, P., Majerus, P.W. & Bovill, E.G. (1993) Inherited predisposition to thrombosis. Cell, 72, 477-480.
22. Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Eisenberg, P.R. & Miletich, J.P. (1995) Mutation in the gene coding for coagulation factor V and the risk of miocardial infarction, stroke, and venous thrombosis in apparently healthy men. New England Journal of Medicine, 332, 912-917.
23. Rosendaal, F.R., Koster, T., Vandenbrouke, J.P. & Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504-1508.
24. Shen, L. & Dahlbäck, B. (1994) Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. Journal of Biological Chemistry, 269, 18735-18738.
25. Stirrat, G.M. (1990) Recurrent miscarriage: definition and epidemiology. Lancet, 336, 673-675.
26. Svensson, P.J. & Dahlbäck, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine, 330, 517-522.
27. Toulon, P., Gris, J.C., LeQuerrec, A. & Marnet, L. (1994) Acquired activated protein C resistance in women taking oral contraceptives. (Abstract). Blood, 84, 260.
28. Vandenbroucke, J.P., Koster, T., Briët, E., Reitsma, P.H., Bertina, R.M. & Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 1453-1457.
29. Varadi, K., Rosing, J., Tans, G. & Schwarz, H.P. (1995) Influence of factor V and factor Va on APC-induced cleavage of human factor VIII. Thrombosis and Haemostasis, 73, 727-738.
30. 506 of factor V. Lancet, 343, 1535-1536.
31. Zöller, B., Svensson, P., He, X. & Dahlbäck, B. (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. Journal of Clinical Investigation, 94, 2521-2524.